Skip to main content
. 2017 Mar 31;2017(3):CD001292. doi: 10.1002/14651858.CD001292.pub3

Schmitz 1999.

Methods Study design: Randomized controlled trial
Setting: Hospital, USA
 Recruitment: women with or at risk of CAD
Participants 2 separate samples recruited:
 53 inpatients with CAD who stopped smoking during hospitalization and wanted to stay quit
 107 women volunteering for cessation treatment who had > 1 CAD risk factor
Interventions Therapists: 2 smoking counsellors + 2 clinical psychology interns
1. Coping skills, relapse prevention, 6 x 1‐hr including stress management, homework
 2. Health Belief model, 6 x 1‐hr, smoking‐related health information about disease state or CAD profile Focus on benefits of stopping
Outcomes Abstinence at 6 m (PP)
 Validation: CO < 9 ppm, urine cotinine < 10 ng/ml
 Not all quitters tested, confirmation rates not reported
Notes Post‐randomization dropouts who did not complete baseline and begin treatment were not included in any data
 Quit rates were lower in the CAD sample than in the at‐risk group
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "Randomly assigned", stratified on smoking rate and myocardial infarction status
Allocation concealment (selection bias) Unclear risk No details given
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Some validation of abstinence, arms had similar intensities of treatment
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Pretreatment dropouts were excluded, all others included in ITT analysis